![A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca-2016-0026/asset/images/medium/figure1.gif)
A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS | Future Cardiology
![A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820300260-fx1.jpg)
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
![A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy](https://www.cell.com/cms/attachment/f7119006-e9eb-45cc-a48a-f2878fe07e4a/gr1.jpg)
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy
![Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/086822a5-b0f9-4079-b310-1dbed43508fa/gr1.jpg)
Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus
A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults - K. Chandrasekhar, Jyoti Kapoor, Sridhar Anishetty,
![Nutrients | Free Full-Text | Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial Nutrients | Free Full-Text | Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial](https://www.mdpi.com/nutrients/nutrients-08-00182/article_deploy/html/images/nutrients-08-00182-g001.png)
Nutrients | Free Full-Text | Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial
![Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/49f40097-6e0d-4932-85b8-0be2c505a647/gr1.gif)
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet
![Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/f9b016fe-bd8d-4a93-a587-d4f33837b0e9/gr1.jpg)
Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice
![Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism - Journal of the American Academy of Child & Adolescent Psychiatry Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/524e116a-843a-4b14-9956-e4235d32ed12/gr1.gif)
Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism - Journal of the American Academy of Child & Adolescent Psychiatry
![Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | Full Text Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-019-0038-9/MediaObjects/42466_2019_38_Fig2_HTML.png)
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | Full Text
![Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea | The BMJ Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea | The BMJ](https://www.bmj.com/content/bmj/327/7414/523/F1.large.jpg)
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea | The BMJ
![The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review](https://hearingreview.com/wp-content/uploads/2017/05/HumesFig1-1000x640.jpg)
The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review
Randomized, double-blind, placebo-controlled clinical trial flow. The... | Download Scientific Diagram
Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity | PLOS ONE
Study design and flow chart of the double blind, placebo controlled and... | Download Scientific Diagram
![Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/c17d2153-ddaa-4c2d-a5f5-e390d6c1e5df/gr1.jpg)
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine
![A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0261561419300822-fx1.jpg)
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect
![Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled Trial - Endocrine Practice Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled Trial - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/f4acc1aa-d40f-42f0-b3db-34d878a7c040/gr1.jpg)
Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled Trial - Endocrine Practice
![3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity 3 month randomised double blind, placebo-controlled phase followed by a 24-month open-label, single-arm phase. The primary endpoint of the trial was to compare the efficiency (4) - The Butterfly Skin Charity](https://debraireland.org/wp-content/uploads/3-month-randomised-double-blind-placebo-controlled-phase-followed-by-a-24-month-open-label-single-arm-phase.-The-primary-endpoint-of-the-trial-was-to-compare-the-efficiency-4.png)